An in vitro examination by Zhi Gao in 2009 revealed that EGCG could demethylate the WIF-1 promoter, reinstating expression and potentially attenuating the Wnt signaling pathway in lung cancer cells [39]. This evidence concerns the gene WIF1 and lung carcinoma.